About Sagimet Biosciences, Inc. 
Sagimet Biosciences, Inc.
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates 
No Company Details Available
Shareholding Snapshot
Shareholding Compare (%holding) 
Majority shareholders
Strategic Entities
Domestic Funds
Held in 23 Schemes (15.75%)
Foreign Institutions
Held by 39 Foreign Institutions (10.22%)
Strategic Entities with highest holding
Highest Public shareholder
Management
Designation
No Data
Revenue and Profits:
Net Sales:
(Quarterly Results - Mar 2026)
Net Profit:
-11 Million
Pharmaceuticals & Biotechnology
USD 157 Million (Micro Cap)
NA (Loss Making)
NA
0.00%
-1.01
-45.82%
1.41






